Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4748861
Max Phase: Preclinical
Molecular Formula: C72H116Cl4N8O8S4
Molecular Weight: 1350.04
Molecule Type: Unknown
Associated Items:
ID: ALA4748861
Max Phase: Preclinical
Molecular Formula: C72H116Cl4N8O8S4
Molecular Weight: 1350.04
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)(C)c1cc2c(OCC(=O)NCCC[N+](C)(C)C)c(c1)Sc1cc(C(C)(C)C)cc(c1OCC(=O)NCCC[N+](C)(C)C)Sc1cc(C(C)(C)C)cc(c1OCC(=O)NCCC[N+](C)(C)C)Sc1cc(C(C)(C)C)cc(c1OCC(=O)NCCC[N+](C)(C)C)S2.[Cl-].[Cl-].[Cl-].[Cl-]
Standard InChI: InChI=1S/C72H112N8O8S4.4ClH/c1-69(2,3)49-37-53-65(85-45-61(81)73-29-25-33-77(13,14)15)54(38-49)90-56-40-51(71(7,8)9)42-58(67(56)87-47-63(83)75-31-27-35-79(19,20)21)92-60-44-52(72(10,11)12)43-59(68(60)88-48-64(84)76-32-28-36-80(22,23)24)91-57-41-50(70(4,5)6)39-55(89-53)66(57)86-46-62(82)74-30-26-34-78(16,17)18;;;;/h37-44H,25-36,45-48H2,1-24H3;4*1H
Standard InChI Key: JZYXQCPGRPZYCN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1350.04 | Molecular Weight (Monoisotopic): 1348.7777 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Padnya PL,Terenteva OS,Akhmedov AA,Iksanova AG,Shtyrlin NV,Nikitina EV,Krylova ES,Shtyrlin YG,Stoikov II. (2021) Thiacalixarene based quaternary ammonium salts as promising antibacterial agents., 29 [PMID:33310546] [10.1016/j.bmc.2020.115905] |
2. Padnya PL,Terenteva OS,Akhmedov AA,Iksanova AG,Shtyrlin NV,Nikitina EV,Krylova ES,Shtyrlin YG,Stoikov II. (2021) Thiacalixarene based quaternary ammonium salts as promising antibacterial agents., 29 [PMID:33310546] [10.1016/j.bmc.2020.115905] |
Source(1):